About Sanix Formulation Private Limited
Data last updated:
Sanix Formulation Private Limited is a private limited company based in Surat, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33119GJ2020PTC118940. Its GSTIN is 24ABFCS1249E1ZM (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Ritu Agrawal and Atul Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Surat, Gujarat.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.61 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net loss of ₹66,989 (net margin -0.1%) and EBITDA of ₹11.82 Lakh (EBITDA margin 1.8%).
The company has about 41 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹34 Lakh on record.
For more details, the company can be reached via its website sanixformulation.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address409 Empire State Building, Ring Road Near Udhana Darwaja, Surat, Gujarat, India – 395002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sanix Formulation Private Limited
The main business activity of Sanix Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sanix Formulation Private Limited FY 2025 filings available
Sanix Formulation Private Limited reported revenue of ₹6.61 Cr (up 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Sanix Formulation Private Limited
Revenue rose 25% in the latest year. EBITDA rose 158% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sanix Formulation Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.82 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹66,989 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Sanix Formulation Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.8% | •••• | •••• | •••• |
| Net Profit Margin | -0.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sanix Formulation are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sanix Formulation Private Limited
Sanix Formulation Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| GMP Formulations Private Limited | ₹6.68 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Hyderabad, Telangana, India |
| Experts Pharmaceuticals Private Limited | ₹6.67 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Ahmedabad, Gujarat, India |
| Aztec Pharma Private Limited | ₹6.65 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Surendra Nagar, Gujarat, India |
| Albios Lifesciences Private Limited | ₹6.63 Cr (FY 2025) | •••• | •••• | 77.0% | •••• | Ahmedabad, Gujarat, India |
| Parth Parenteral Private Limited | ₹6.62 Cr (FY 2016) | •••• | •••• | -52.0% | •••• | Gujarat, India |
| Sanix Formulation Private Limited this company | ₹6.61 Cr (FY 2024) | •••• | •••• | 25.0% | •••• | Surat, Gujarat, India |
| Fedley Healthcare Private Limited | ₹6.61 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Raipur Rani, Haryana, India |
| Winy Healthcare Private Limited | ₹6.6 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Agra, Uttar Pradesh, India |
| Affigenix Biosolutions Private Limited | ₹6.6 Cr (FY 2025) | •••• | •••• | 105.0% | •••• | Chennai, Tamil Nadu, India |
| Water Dna Private Limited | ₹6.6 Cr (FY 2022) | •••• | •••• | 27.0% | •••• | Chennai, Tamil Nadu, India |
| Darius Healthcare and Management Services Private Limited | ₹6.59 Cr (FY 2024) | •••• | •••• | 137.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Sanix Formulation by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sanix Formulation Private Limited
Sanix Formulation Private Limited is audited by B A N C R S AND CO LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B A N C R S AND CO LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sanix Formulation Private Limited
Sanix Formulation has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritu Agrawal | Director | 18 Dec 2020 | 5 Years 9 Months | Current |
| Atul Agrawal | Additional Director | 15 Jul 2023 | 3 Years 2 Months | Current |
Ownership and Shareholding of Sanix Formulation Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sanix Formulation Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2025 | Hdfc Bank Limited | ₹34 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Sanix Formulation Private Limited
Sanix Formulation Private Limited has a workforce of 41 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sanix Formulation Private Limited
Sanix Formulation Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Atul Agrawal was appointed as Additional Director on 15 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Sanix Formulation Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sanix Formulation Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sanix Formulation Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sanix Formulation Private Limited
Sanix Formulation has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ABFCS1249E1ZM | Gujarat | Active | 08 Feb 2021 |
| 23ABFCS1249E1ZO | Madhya Pradesh | Active | 05 Dec 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sanix Formulation Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanix Formulation Private Limited
Sanix Formulation is an active private limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 December 2020 (6+ years old) and is registered under CIN U33119GJ2020PTC118940.
Sanix Formulation reported revenue of ₹6.61 Cr for FY 2024 (up 25% YoY).
Sanix Formulation has 2 current directors:
- Ritu Agrawal - Director
- Atul Agrawal - Additional Director
Sanix Formulation reported a net loss of ₹66,989 (net margin -0.1%) and EBITDA of ₹11.82 Lakh (EBITDA margin 1.8%) for FY 2024, as per its filed financial statements.
The GSTIN of Sanix Formulation is 24ABFCS1249E1ZM, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 23ABFCS1249E1ZO (Madhya Pradesh).
The CIN (Corporate Identification Number) of Sanix Formulation is U33119GJ2020PTC118940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanix Formulation was incorporated on 18 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Sanix Formulation by revenue are GMP Formulations Private Limited, Experts Pharmaceuticals Private Limited, Aztec Pharma Private Limited, Albios Lifesciences Private Limited, Parth Parenteral Private Limited and 5 more, all in the Pharma industry (Formulations).
Atul Agrawal was appointed as Additional Director on 15 Jul 2023. Vaishali Ashish Agrawal ceased to be Director on 15 Jul 2023. Suyash Agrawal ceased to be Director on 09 Jan 2023. Sanix Formulation has 6 board changes on record in total.
Yes, Sanix Formulation is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Sanix Formulation can be reached through the website sanixformulation.com. Its registered office is in Surat, Gujarat, India.